General Archive
-
ArticlesThe pandemic – a driving force for innovation in diagnostics?
Ciaran Fulton, Head of Diagnostics, reflects on the rapid evolution of diagnostics during the pandemic.
-
News releasesKQ Labs announces the graduation of its third cohort in a highly successful Demo Day event
KQ Labs will be opening its next cohort for applications in early May 2021
-
ArticlesInternational Women’s Day 2021 – salute to women trailblazing innovation
Anji Miller, Senior Business Manager and advocate for diversity, discusses representation in science for International Women’s Day 2021.
-
News releasesLifeArc and Action Medical Research announce commitment of over £1m to research into rare diseases in children
Demonstrates our focus on improving the lives of people living with rare diseases.
-
News releasesRepurposing drugs: the opportunity and the challenges
Sign up for our seminar on intellectual property, regulation, commercial positioning and patient involvement.
-
News releasesLifeArc provides £5 million funding to increase understanding of the role of genetic risk factors in patient response to COVID-19
Medical research charity, LifeArc, announces today that it is providing £5 million funding to support the work of the GenOMICC…
-
ArticlesCelebrating UN International Day of Women and Girls in Science 2021
At a time when the world is looking to science for the answers, LifeArc marks the UN’s International Day of…
-
News releasesLifeArc invests £10 million in Illumina Accelerator to Advance Genomics Startups
LifeArc announced today a £10 million cornerstone investment in the funding cycle of Illumina Accelerator Cambridge. This is part of…
-
News releasesLifeArc working with the Crohn’s & Colitis Foundation to develop a prognostic test for Crohn’s disease in children
A new partnership between LifeArc and the US-based Crohn’s & Colitis Foundation (Foundation) aims to progress encouraging research that could…
-
News releasesMetrion Biosciences and LifeArc further extend neuroscience-focused ion channel drug discovery collaboration
Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, and LifeArc, a leading UK independent medical…
-
News releasesLifeArc funds COVID-19 drug screening hub at the University of Glasgow
A new COVID-19 drug screening and resistance hub will be established in Scotland, based at the MRC-University of Glasgow Centre…
-
News releasesLifeArc co-leads £6 million funding in DJS Antibodies
LifeArc announces Seed Fund investment of £2 million in DJS Antibodies, a biotech start-up company pioneering the development of novel…